Expert Interview
A look at the use of GLP-1 agonists and factors affecting prescribing patterns and insurance coverage for these agents with an Endocrinologist.
Ticker(s): LLY, NVOInstitution: NYU Langone Health
- Clinical Assistant Professor, Department of Medicine at NYU Grossman School of Medicine
- Specializes in Endocrinology and Obesity Medicine
- Has prescribed Wegovy to >500 pts, Mounjaro >200 patients per year
- can speak to the degree of insurance coverage and how it differs between obesity vs. diabetes, Medicare vs. commercial insurance
Do you want answers to these questions?
Slingshot Insights Explained
Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.
Reason
*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.
